[
  {
    "ts": null,
    "headline": "Gilead: Expansion Of Livdelzi For PBC Continues With European Marketing Approval",
    "summary": "Gilead Sciences sees strong growth in HIV & oncology with BIKTARVY & TRODELVY. Learn about upcoming drugs & market potential for 2024.",
    "url": "https://finnhub.io/api/news?id=5cfa6a663c0d174404a041d52d80f01a99c0befe5d6ffa3ebf56b6050c965f60",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742733367,
      "headline": "Gilead: Expansion Of Livdelzi For PBC Continues With European Marketing Approval",
      "id": 133330583,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2205820023/image_2205820023.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Gilead Sciences sees strong growth in HIV & oncology with BIKTARVY & TRODELVY. Learn about upcoming drugs & market potential for 2024.",
      "url": "https://finnhub.io/api/news?id=5cfa6a663c0d174404a041d52d80f01a99c0befe5d6ffa3ebf56b6050c965f60"
    }
  }
]